As Colorado approaches its fourth year of legal marijuana, consumers around the state are still struggling with the issue of acceptance. With local governments passing restrictive laws aimed at preventing the public consumption and/or display of marijuana, marijuana consumers are being forced to enjoy their legally purchased products behind closed doors. Take Denver for example. In 2013, City Council members passed an ordinance that established fines of up to $999 for those who are caught smoking in a public space. This left in state consumers with nowhere to consume their marijuana other than a private residence, and left out-of-state consumers with no legal place to consume at all.
After the new law was put into place, Denver police officers issued more than 650 tickets within the first year, compared to just over 117 for the previous year. This massive increase of 461 percent in citations speaks volumes to the obvious need for a more thoughtful approach. It just doesn’t make sense to provide a legal avenue for adults to purchase marijuana while simultaneously applying restrictions that severely limit the act of consuming it. It’s fairly simple, marijuana consumers deserve similar rights that our society typically affords to someone who enjoys a glass of wine at a local wine bar after an exhausting day.
Hopefully this situation will soon change. Last week Denver NORML filed the Responsible Use initiative with the city of Denver. If passed by voters this November, it would legalize the establishment of private marijuana clubs for adults 21 and up. Passage of this ordinance would be a historic first step in moving towards the ultimate goal of normalizing the consumption of marijuana in our country. The initiative would provide responsible adults a legally defined space where marijuana could be consumed and shared with other like-minded adults — a simple, yet necessary accommodation for states that have passed some form of legalization. It’s time for marijuana consumers to embrace the idea that just like any other consumer focused industry, we have rights.
We have our work ahead of us: gathering signatures, voter outreach and coalition building will be our top priorities over the next few weeks. Even in a progressive city such as Denver, where marijuana is fairly popular, we must work to earn the support non-consumers to ensure a victory on this issue. I believe we can accomplish this by offering a pragmatic initiative that will focus on the basics. There are plenty of places to grab a drink or a quick bite to eat, but we as marijuana consumers have no where to legally consume marijuana other than the privacy of someone’s home. If we focus on what is truly needed, I believe we can increase our chances of being successful this November.
To learn more about the Responsible Use Initiative or to get involved, please visit the campaign’s website by clicking, here!
If you are planning on attending this year’s Congressional Lobby Day in Washington D.C. this May 23rd and 24th and you like saving money, please take advantage of the early bird discount for pre-registering that is now available!
The schedule will be released soon but rest easy it will be a full two day itinerary focused around marijuana consumerism, the 114th Congress, post prohibition concerns, marijuana in the media and more! We’ll hold our informational conference on Monday at the GW University Elliot School of International Affairs (1957 E Street NW) with moderated discussions between some of the most influential thought leaders in the movement and then on Tuesday we’ll #TakeAction and gather on Capitol Hill to lobby our elected officials for common sense marijuana law reforms.
We’ll also be hosting a NORML Social at O St. Mansion on Monday night for a special award ceremony to honor our most valuable marijuana activists! If you wish to join the party don’t forget to purchase a separate ticket at checkout.
Thanks again for your dedicated support and help in reforming our country’s misguided cannabis laws.
After months of delay, members of Pennsylvania’s House of Representatives finally approved legislation to permit the production and use of medical marijuana products to qualified patients.
House members decided yesterday in favor of an amended version of Senate Bill 3. The measure passed by a vote of 149 to 43.
The amended bill permits state officials to license up to 25 marijuana cultivators and up to 25 dispensaries to provide cannabis products to qualified patients who possess a recommendation from select physicians. Qualifying conditions eligible to receive cannabis therapy include chronic pain, multiple sclerosis, HIV/AIDS, cancer, epilepsy, and inflammatory bowel disease, among others. The measure permits for the dispensing of herbal cannabis via vaporization, as well as the use of marijuana-infused extracts or oils, but it does not permit smoking.
Because the House-amended legislation differs from the version initially approved by the Senate, the bill must be re-approved by the Senate or it will be negotiated in conference committee. Governor Tom Wolf supports patients’ access to medical cannabis and has pledged to sign the bill once it reaches his desk.
Derek Rosenzweig of PhillyNORML, which has been lobbying on behalf of medical cannabis access legislation since 2009, said: “This is a historic day in Pennsylvania. Hopefully during concurrence they can fix some of the flaws in the bill.”
Once signed into law, Pennsylvania will become the 24th state to permit the use of physician-recommended cannabis.
Legislative sessions around the country are moving quickly with several already coming to a close. It’s important to stay updated on pending measures in your state because NOW is the time to contact your elected officials using our #TakeAction Center urging their support for marijuana law reform. Keep reading to get this week’s latest legislative highlights!
Florida: House and Senate lawmakers have approved legislation, House Bill 307, to permit medical marijuana access to people diagnosed with terminal illnesses. Florida law already permits for the production of strains of cannabis high in CBD to be dispensed to qualified patients with cancer, muscle spasms, and intractable seizures. However, to date, this program has yet to be operational. House Bill 307 seeks to expand state-licensed medical marijuana production to also include strains dominant in THC. The measure now awaits action from Florida Governor Rick Scott.
Maine: The Campaign To Regulate Marijuana Like Alcohol, a ballot initiative that is seeking to put the question of marijuana legalization before voters in the state this November, is suing the state of Maine for invalidating 26,779 signatures. The campaign had originally turned in 99,229 signatures from registered voters by the February 1st deadline in hopes of meeting the required number of 61,123 valid signatures to make the ballot. Secretary of State Matt Dunlap invalidated the signatures because the signature of the notary who signed the petitions allegedly did not match the signature on file with staff.
Nebraska: Legislation remains pending, LD 643: the Cannabis Compassion and Care Act, to permit qualified patients to legally possess and cultivate cannabis. The measure permits patients permits patients to grow up to 12 plants and/or to possess up to six ounces of cannabis for therapeutic purposes. The bill also establishes licensed compassion centers to provide cannabis to qualified patients. #TakeAction
New York: Legislation has been introduced, A 9510, to expand the pool of medical professionals who can provide written recommendations for marijuana to qualifying patients. If passed, the legislation would allow physician assistants and nurse practitioners who are in good standing with the state to provide written certifications to qualifying patients. New York legalized medical marijuana in 2014, however the law is one of the most restrictive in the country. Patients may only use non-smokable forms of marijuana and many are struggling to find physicians who can certify them access to medical marijuana preparations. This pending legislation would increase the number of medical professionals eligible to participate in the program, thereby increasing access to those patients who so desperately need it. #TakeAction
Oklahoma: House lawmakers have approved legislation, House Bill 2835, to expand the pool of patients eligible to possess cannabidiol (CBD) under a physician’s authorization. If passed, those with Alzheimer’s disease, dementia, chronic pain, neuropathic pain, spasticity due to multiple sclerosis or due to paraplegia, intractable nausea and vomiting, appetite stimulation with chronic wasting diseases, and/or attention deficit hyperactivity disorder or bipolar affective disorder would be allowed access to CBD. The bill now awaits Senate action. #TakeAction
Utah: Lawmakers have adjourned for 2016 without taking action to expand medical cannabis access to seriously ill patients. Members of the House Health and Human Services Committee voted 8-4 on Monday, March 7, against the passage of Senate Bill 73, the Medical Cannabis Act. A separate measure, SB 89, was approved by members of a House committee however, lawmakers ultimately failed to back the measure, alleging that the law would be too expensive to implement.
Vermont: Members of various House Committee are anticipated to begin taking testimony next week with regard to Senate Bill 241, to regulate the adult use, production, and sale of cannabis. Members of the Senate previously voted 17 to 12 in favor of the legislation, which is backed by Gov. Shumlin. Now the measure faces a potentially uphill battle in the House, starting with the House Judiciary Committee. It is vital that House representatives hear from you in support of SB 241. #TakeAction
Virginia: Members of the House of Delegates and the Senate have decided in favor of Senate Bill 701, which permits for the in-state production of therapeutic oils high in cannabdiol and/or THC-A (THC acid). The Governor has untilApril 11 to act on the bill. #TakeAction
Washington: Governor Jay Inslee decided on Wednesday, March 9th, to veto legislation, Senate Bill 6206, which sought to establish licensed hemp production. House and Senate lawmakers had previously approved legislation, which would have authorized “The growing of industrial hemp as a legal agricultural activity” in accordance with federal legislation permitting such activity as part of a state-authorized program.
The enactment of statewide laws permitting the physician-authorized use of cannabis therapy has not stimulated increases in marijuana use by young people, according to findings published in The International Journal on Drug Policy.
A team of researchers from Columbia University in New York City reviewed federal data regarding rates of self-reported, monthly marijuana use among 12 to 17-year-olds between the years 2002 and 2011.
While the study’s authors acknowledged that many medical marijuana states possess greater overall rates of youth cannabis use compared to non-medical states, they affirmed that these jurisdictions already possessed elevated use rates prior to changes in law, and that the laws’ enactment did not play a role in influencing youth use patterns.
“While states with MML (medical marijuana laws) feature higher rates of adolescent marijuana use, to date, no major U.S. national data set, including the NSDUH (US National Survey on Drug Use in Households), supports that MML are a cause of these higher use levels,” investigators concluded. “[W]hen within-state changes are properly considered and pre-MML prevalence is properly controlled, there is no evidence of a differential increase in past-month marijuana use in youth that can be attributed to state medical marijuana laws.”
Their findings are similar to those of a separate 2015 study assessing the relationship between state medical marijuana laws and rates of self-reported adolescent marijuana use over a 24-year period in a sampling of over one million adolescents in 48 states. Researchers in that study reported no increase in teens’ overall cannabis use that could be attributable to changes in law, and acknowledged a “robust” decrease in consumption among 8th graders. They concluded “[T]he results of this study showed no evidence for an increase in adolescent marijuana use after the passage of state laws permitting use of marijuana for medical purposes. … [C]oncerns that increased marijuana use is an unintended effect of state marijuana laws seem unfounded.”
The abstract of the study, “Prevalence of marijuana use does not differentially increase among youth after states pass medical marijuana laws: Commentary on and reanalysis of US National Survey on Drug Use in Households data 2002-2011,” appears online here.